Figure 2 Treatment responses to... | American Society of Hematology

Figure 2

$Figure 2. Treatment responses to pomalidomide in patients with RRMM. (A) ITT population (N = 38). (B) Dual lenalidomide and bortezomib–refractory patients (N = 24).$

Treatment responses to pomalidomide in patients with RRMM. (A) ITT population (N = 38). (B) Dual lenalidomide and bortezomib–refractory patients (N = 24).

This Feature Is Available To Subscribers Only